Charlie Hospital Semarang Tbk. vs Summarecon Agung Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Summarecon Agung Tbk. trades at Rp322 (market cap 5.05T, 29.26M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 6.8× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 29.26M). Which is the better fit depends on your goals.
| RSCH | SMRA | |
|---|---|---|
Market Cap | 742B | 5.05T |
Volume | 29.45M | 29.26M |
Lot | 294.49K | 292.59K |
Turnover | 8.14B | 9.3B |
Average Price | 276.35 | 317.73 |
Value | 8.14B | 9.3B |
Indicative Equilibrium Price | 270 | 322 |
Indicative Equilibrium Volume | 103 | 3.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →